TD Cowen Reiterates Buy Rating for BrightSpring Health Services

TD Cowen has reiterated its buy rating on BrightSpring Health Services, Inc. (NasdaqGS: BTSG) with a price target of $81. This update came on June 18, 2026, as shares of BrightSpring traded around $64.43.

Other Institutional Activity in BrightSpring Health Services

Several institutional investors have adjusted their positions in BrightSpring. Kohlberg Kravis Roberts & Co. L.P. reduced its holdings by 20,117,773 shares, leaving it with 41,824,259 shares valued at approximately $1.78 billion. On the other hand, BlackRock, Inc. increased its stake by 2,615,897 shares, ending with 19,602,159 shares worth about $835.25 million. Invesco Ltd. also added to its position, increasing its holdings by 886,924 shares to a total of 11,482,156 shares valued at $489.25 million.

BrightSpring Health Services Stock Snapshot

Shares of BrightSpring Health Services, Inc. (NasdaqGS: BTSG) traded near $64.43. The company has a market capitalization of $12.64 billion and a P/E ratio of 83.68, with a forward P/E of 30.49. Its beta is 1.874, indicating higher volatility compared to the market. BrightSpring's stock has seen a 52-week low of $19.01 and a high of $65. The 50-day moving average is $54.50, and the 200-day moving average is $40.31.

Recent Earnings

In its most recent earnings report, BrightSpring Health Services reported revenue of $13.65 billion, reflecting a growth rate of 25.6%. The company achieved a net margin of 2.27% and a return on equity of 9.23%. Earnings per share were $0.77. The next earnings release is scheduled for July 31, 2026.

Insider Buying and Selling at BrightSpring Health Services, Inc.

Recent insider transactions at BrightSpring included Chairman, President, and CEO Jon Rousseau selling 260,000 shares on June 5, 2026. Lisa Nalley, Chief of Staff and Senior Vice President of Human Resources, sold 35,000 shares at an average price of $58.75 on the same day. Meanwhile, Nigam Shah purchased 4,013 shares on June 11, 2026.

Analysts Set New Price Targets

On June 18, 2026, TD Cowen maintained its buy rating on BrightSpring with a price target of $81. Earlier this month, on June 8, Goldman Sachs initiated coverage with a buy rating and a target of $71. Morgan Stanley maintained its buy rating with a $71 target on June 2.

About BrightSpring Health Services

BrightSpring Health Services, Inc., headquartered in Louisville, Kentucky, provides home and community-based healthcare services across the United States. The company operates through its Pharmacy Solutions and Provider Services segments, offering clinical and supportive care in home and community settings to various populations, including those covered by Medicare and Medicaid. The company, led by CEO Jon B. Rousseau, employs approximately 23,500 people.

Bottom Line

TD Cowen's reiterated buy rating and increased price target highlight confidence in BrightSpring Health Services' growth prospects. Investors closely monitor such updates as they provide insights into potential market movements. It's important to remember that analyst ratings are based on available data and projections, which can change over time.